SCHEMBL1101897

SCHEMBL1101897

Cc1ccc(C(=O)c2ccc(O)cc2O)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.68
MEN1 O00255 4/20 0.68
USP2 O75604 1/20 0.68
GAA P10253 1/20 0.68
KEAP1 Q14145 1/20 0.68
NFE2L2 Q16236 1/20 0.68
ALDH1A1 P00352 6/20 0.68
NPC1 O15118 4/20 0.68
TP53 P04637 2/20 0.68
HPGD P15428 2/20 0.68
MAPT P10636 2/20 0.68
SMN1; SMN2 Q16637 1/20 0.68
ESR1 P03372 1/20 0.55
ESR2 Q92731 1/20 0.55
LMNA P02545 3/20 0.54
CES2 O00748 1/20 0.53
CA12 O43570 3/20 0.52
CA1 P00915 3/20 0.52
CA2 P00918 3/20 0.52
CA7 P43166 3/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30375015 1.00 KMT2A (0.68) KMT2AMEN1USP2GAAKEAP1
SCHEMBL10735111 0.90 MEN1 (0.81) KMT2AMEN1USP2GAAKEAP1
SCHEMBL15044104 0.89 NPC1 (0.58) KMT2AMEN1USP2GAAKEAP1
SCHEMBL11350747 0.89 NPC1 (0.64) KMT2AMEN1USP2GAAKEAP1
SCHEMBL29375096 0.88 MEN1 (0.78) KMT2AMEN1USP2GAAKEAP1
SCHEMBL93420 0.88 MEN1 (0.78) KMT2AMEN1USP2GAAKEAP1
SCHEMBL10354488 0.86 MEN1 (0.75) KMT2AMEN1USP2GAAKEAP1
SCHEMBL30374726 0.85 KMT2A (0.62) KMT2AMEN1USP2GAAKEAP1
SCHEMBL5710064 0.85 KMT2A (0.62) KMT2AMEN1USP2GAAKEAP1
SCHEMBL11230455 0.85 CES2 (0.57) KMT2AMEN1USP2GAAKEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1704244-A2 METHODS, COMPOSITIONS, AND KITS FOR ANALYSIS OF ENZYME ACTIVITY IN CELLS Applera Corporation, Applied Biosystems Group (US) 2006-09-27 EP claimed
WO-2005059163-A2 METHODS, COMPOSITIONS, AND KITS FOR ANALYSIS OF ENZYME ACTIVITY IN CELLS APPLERA CORPORATION (US) 2005-06-30 WO claimed
JP-5311151-A None JP disclosed
US-20260062580-A1 REVERSIBLY THERMOCHROMIC COMPOSITION, REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT ENCAPSULATING REVERSIBLY THERMOCHROMIC COMPOSITION, AND WRITING INSTRUMENT USING REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT THE PILOT INK CO., LTD. (JP) 2026-03-05 US disclosed
EP-3954745-B1 REVERSIBLY THERMOCHROMIC AQUEOUS INK COMPOSITION FOR WRITING UTENSILS, AND REFILL AND WATER-BASED BALLPOINT PEN EACH INTERNALLY CONTAINING SAME KK PILOT CORPORATION ALSO TRADING AS PILOT CORPORATION (JP) 2026-01-07 EP disclosed
US-12460099-B2 Reversibly thermochromic composition, reversibly thermochromic microcapsule pigment encapsulating reversibly thermochromic composition, and writing instrument using reversibly thermochromic microcapsule pigment THE PILOT INK CO., LTD. (JP) 2025-11-04 US disclosed
US-12421411-B2 Aqueous ink composition for reversibly thermochromic writing instrument, and refill and aqueous ballpoint pen incorporating aqueous ink composition for reversibly thermochromic writing instrument KABUSHIKI KAISHA PILOT CORPORATION (JP) 2025-09-23 US disclosed
CN-113646052-B Reversible thermochromic composition, reversible thermochromic microcapsule pigment, and writing instrument 百乐墨水株式会社 2024-05-17 CN disclosed
CN-113785023-B Water-based ink composition for reversible thermochromic writing instrument, refill for refill and water-based ballpoint pen incorporating same 株式会社百乐 2023-05-12 CN disclosed
US-20230018132-A1 REVERSIBLY THERMOCHROMIC AQUEOUS INKJET PRINTER INK COMPOSITION, INKJET PRINTER AND INK CARTRIDGE USING THE SAME RISO TECHNOLOGIES CORPORATION (JP) 2023-01-19 US disclosed
US-20220251406-A1 AQUEOUS INK COMPOSITION FOR REVERSIBLY THERMOCHROMIC WRITING INSTRUMENT, AND REFILL AND AQUEOUS BALLPOINT PEN INCORPORATING AQUEOUS INK COMPOSITION FOR REVERSIBLY THERMOCHROMIC WRITING INSTRUMENT KABUSHIKI KAISHA PILOT CORPORATION (ALSO TRADING AS PILOT CORPORATION) (JP) 2022-08-11 US disclosed
US-4323710-A A NONAQUEOUS SOLVENT OF POLYOXYETHYLENE GLYCOL OR ITS ALKYLATED DERIVATIVES GAF CORPORATION (US) 1982-04-06 US disclosed
US-4273844-A Heat-developable photosensitive member for forming electrostatic printing masters CANON KABUSHIKI KAISHA (JP) 1981-06-16 US disclosed
US-4256626-A 2-BENZIMIDAZOLYL-, 2-BENZOTHIAZOLYL-, OR 2-INDOLYL-PHENYL DERIVATIVES LINKED TO A 2-HYDROXYBENZOPHENONE EASTMAN KODAK COMPANY (US) 1981-03-17 US disclosed
US-4237213-A THERMOGRAPHY; PHOTOSENSITIVE MATERIAL CONTAINING ORGANIC SILVER SALT, HALIDE, AND BINDER CANON KABUSHIKI KAISHA (JP) 1980-12-02 US disclosed
US-4174321-A POLYMERIC MOLDING MATERIALS EASTMAN KODAK COMPANY (US) 1979-11-13 US disclosed
US-4127501-A BENZOXAZOLE, BENZOTHIAZOLE, BENZIMIDAZOLE, BENZOTRIAZOLE OR INDOLE DERIVATIVES EASTMAN KODAK COMPANY (US) 1978-11-28 US disclosed
US-4115348-A DEGRADATION INHIBITORS EASTMAN KODAK COMPANY (US) 1978-09-19 US disclosed
US-4073745-A Multichromophoric benzotriazole ultraviolet stabilizers and their use in organic compositions EASTMAN KODAK COMPANY (US) 1978-02-14 US disclosed
US-3981884-A POLYMERS EASTMAN KODAK COMPANY (US) 1976-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260062580-A1 REVERSIBLY THERMOCHROMIC COMPOSITION, REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT ENCAPSULATING REVERSIBLY THERMOCHROMIC COMPOSITION, AND WRITING INSTRUMENT USING REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT TYR, SCO2, HBB KMT2A 2763/4885MEN1 1317/4885USP2 4062/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.